The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck KGaA
 
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck KGaA; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck KGaA; Pfizer; Roche
Tepotinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) with MET amplification (METamp).
 
Xiuning Le
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Lilly; EMD Serono; Lilly; Spectrum Pharmaceuticals
Research Funding - Boehringer Ingelheim (Inst); Lilly (Inst)
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Ipsen; Lilly; Merck Serono; Mirati Therapeutics; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi; Servier; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Jan Van Meerbeeck
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Santiago Viteri
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; Merck; Merck Serono; ose pharma; Puma Biotechnology; Roche
 
Carlos Cabrera Galvez
Honoraria - Boehringer Ingelheim; Roche
Consulting or Advisory Role - Boehringer Ingelheim
Travel, Accommodations, Expenses - Roche
 
David Vicente Baz
No Relationships to Disclose
 
Young-Chul Kim
Honoraria - AstraZeneca; Boehringer Ingelheim; Roche
Research Funding - AstraZeneca; Boehringer Ingelheim; Roche
 
Jin-Hyoung Kang
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; Roche; Yuhan
Speakers' Bureau - MSD; Pfizer; Roche
Research Funding - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Yuhan
 
Karl-Maria Schumacher
No Relationships to Disclose
 
Niki Karachaliou
Employment - Merck KGaA
 
Svenja Adrian
Employment - Merck KGaA
 
Rolf Bruns
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
 
Paul K. Paik
Honoraria - AstraZeneca; Bicara Therapeutics; Boehringer Ingelheim; Calithera Biosciences; EMD Serono; GlaxoSmithKline; Takeda; Xencor
Consulting or Advisory Role - AstraZeneca; Bicara Therapeutics; Boehringer Ingelheim; Calithera Biosciences; EMD Serono; GlaxoSmithKline; Takeda; Xencor
Research Funding - Bicara Therapeutics; Boehringer Ingelheim; EMD Serono